Some studies showed that high PD-L1 expression was associated with tumor metastasis, cancer recurrence, and tumor invasion; PD-L1 could be considered an independent element in evaluating immunotherapy during metastasis [27,28]. The gene discussed is CD274; the disease is cancer.